US$ 29.88
glp 1 drugs news Medicare is about to cover GLP-1 for weight loss. Here's what to know New research is taking a
Description
Glob Open
Back Pincock, S (29 July 2006) 'Ellis Samols', The Lancet , 368/9533, 360
Glucagon-like peptide-1 reduces pancreatic -cell mass through hypothalamic neural pathways in high-fat diet-induced obese rats

Patent expiry in March 2026 invites further generics, potentially accelerating volume but pressuring branded margins within the Latin America GLP-1 agonists market

Generative molecular design in low data regimes

Kajikawa M, Higashi Y